ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 7.62
-0.03 (-0.39%)
Jun 22, 2026, 4:00 PM EDT
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 3.79 billion as of June 22, 2026. Its market cap has decreased by -3.79% in one year.
Market Cap
3.79B
Enterprise Value
3.81B
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
7.62
Market Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 3.79B, an increase of 78.94%. That is a compound annual growth rate of 3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 3.79B | -20.29% |
| Dec 31, 2025 | 4.76B | 49.45% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Bioperfectus Technologies | 4.10B |
| Beijing Scitop Bio-tech | 4.06B |
| Lifecome Biochemistry | 3.81B |
| Assure Tech (Hangzhou) | 3.79B |
| Beijing Bohui Innovation Biotechnology Group | 3.64B |
| Kexing Biopharm | 3.59B |
| Shanghai Shen Lian Biomedical | 3.52B |
| Pulike Biological Engineering | 3.50B |